Aaron Tooley

Aaron Tooley, Ph.D., serves as a Scientist 2 in Cancer Cell Biology at REVOLUTION Medicines since June 2021, focusing on target validation, assay development, and overseeing in vitro Pharmacology reports for IND filings. Previously, as a Scientist 1, Tooley contributed to understanding mechanisms of RAS-driven cancers. Doctoral training was completed at the University of Michigan Medical School, specializing in the mTOR signaling pathway, after earning a Master’s Degree in Cell and Molecular Biology from San Francisco State University and a Bachelor’s Degree in Biology from Western Kentucky University. Additional experience includes roles as a Graduate Student Instructor, Genentech Campus Ambassador, and various teaching and research positions at both the undergraduate and high school levels.